These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20399668)

  • 1. A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
    Yuan ZH; Jiang JK; Huang WD; Pan J; Zhu JY; Wang JZ
    J Clin Neurosci; 2010 Jun; 17(6):685-93. PubMed ID: 20399668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
    Steiner T; Diringer MN; Schneider D; Mayer SA; Begtrup K; Broderick J; Skolnick BE; Davis SM
    Neurosurgery; 2006 Oct; 59(4):767-73; discussion 773-4. PubMed ID: 17038942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2008 May; 358(20):2127-37. PubMed ID: 18480205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    Stroke; 2005 Jan; 36(1):74-9. PubMed ID: 15569871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA; Brun NC; Begtrup K; Broderick J; Davis S; Diringer MN; Skolnick BE; Steiner T;
    N Engl J Med; 2005 Feb; 352(8):777-85. PubMed ID: 15728810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
    Mayer SA; Brun NC; Broderick J; Davis SM; Diringer MN; Skolnick BE; Steiner T;
    Neurocrit Care; 2006; 4(3):206-14. PubMed ID: 16757825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
    Mayer SA; Davis SM; Skolnick BE; Brun NC; Begtrup K; Broderick JP; Diringer MN; Steiner T;
    Stroke; 2009 Mar; 40(3):833-40. PubMed ID: 19150875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
    Gladstone DJ; Aviv RI; Demchuk AM; Hill MD; Thorpe KE; Khoury JC; Sucharew HJ; Al-Ajlan F; Butcher K; Dowlatshahi D; Gubitz G; De Masi S; Hall J; Gregg D; Mamdani M; Shamy M; Swartz RH; Del Campo CM; Cucchiara B; Panagos P; Goldstein JN; Carrozzella J; Jauch EC; Broderick JP; Flaherty ML;
    JAMA Neurol; 2019 Dec; 76(12):1493-1501. PubMed ID: 31424491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2008 Mar; 39(3):850-6. PubMed ID: 18239180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing the risk of ICH enlargement.
    Wartenberg KE; Mayer SA
    J Neurol Sci; 2007 Oct; 261(1-2):99-107. PubMed ID: 17631908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemostatic drug therapies for acute spontaneous intracerebral haemorrhage.
    Al-Shahi Salman R
    Cochrane Database Syst Rev; 2009 Oct; (4):CD005951. PubMed ID: 19821350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
    Selin S; Tejani A
    Issues Emerg Health Technol; 2006 Mar; (82):1-4. PubMed ID: 16602203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
    Mayer SA; Rincon F
    Semin Hematol; 2006 Jan; 43(1 Suppl 1):S70-6. PubMed ID: 16427389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
    Diringer MN; Ferran JM; Broderick J; Davis S; Mayer SA; Steiner T; Brun NC; Skolnick BE; Christensen MC
    Cerebrovasc Dis; 2007; 24(2-3):219-25. PubMed ID: 17630481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
    Mayer SA
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S235-40. PubMed ID: 12404092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials.
    Hsia CC; Chin-Yee IH; McAlister VC
    Ann Surg; 2008 Jul; 248(1):61-8. PubMed ID: 18580208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage.
    Le Roux P; Pollack CV; Milan M; Schaefer A
    J Neurosurg; 2014 Aug; 121 Suppl():1-20. PubMed ID: 25081496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
    Davis SM; Broderick J; Hennerici M; Brun NC; Diringer MN; Mayer SA; Begtrup K; Steiner T;
    Neurology; 2006 Apr; 66(8):1175-81. PubMed ID: 16636233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant activated factor VII for acute intracerebral hemorrhage.
    Mayer SA
    Stroke; 2007 Feb; 38(2 Suppl):763-7. PubMed ID: 17261734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
    Diringer MN; Skolnick BE; Mayer SA; Steiner T; Davis SM; Brun NC; Broderick JP
    Stroke; 2010 Jan; 41(1):48-53. PubMed ID: 19959538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.